Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APP/RK

General Information

Transgene: APP RK cDNA

Mutation: a-secretion is reduced by the substitution of two basic with two acidic residues in the a-secretase cleavage site.  Lysine 687 replaced with glutamic acid, Arginine 684 replaced with aspartic acid. (K687E, R684D). 

Promoter:  mouse Thy-1 gene promoter

Mouse Strain: FVB/N

Phenotype

Neuropathological Analysis

APP/RK Tg mice exhibited stronger immunoreactivity in neurons of the cortex, amygdala and striatum, but also in the granular layer of the dentate gyrus, which hardly contains APP in the wt mice.

APP/RK Tg displayed extensive apoptosis in hippocampus and cortex, also displayed an aberrant staining pattern for synaptophysin due to loss of neurites.

No differences observed in Timm stain between wt and APP/RK mice.

Behavioral

Homozygous APP/RK Tg exhibited posture freezing when exposed to a new environment as early as 12 weeks.  The corner corssing scores of the Tg mice age 17-30 week was significantly lower compared to that the non-transgenic.

In Open Field test, Tg mice exhibited a reduced locomotor activity during the first 5 minutes.

APP/RK mouse exhibits premature death, increased aggression, decreased locomotor activity, increased spontaneous seizures, age dependency of neophobic reaction, functional disturbance and hypo-sensitivity to glutamate receptor agonists (NMDA), but none of the typical neuropathological hallmarks of AD such as amyloid deposition and tau pathology are detected in the brain

Availability

Licensing/academic distribution contact information:

Paul Van Dun
Director - KULeuvenR&D
Groot Begijnhof 59
B-3000 Leuven Belgium
tel +32 16 326508
fax +32 16 326515
Email: Paul.Vandun@lrd.kuleuven.ac.be
Web site: http://www.kuleuven.ac.be/lrd

Patents: None

Reference

Primary:

Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 1996 Mar 15;15(6):1265-74. Abstract.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad